This test is most useful if any of these apply to you.
Standard liver panels measure enzymes that leak out of damaged liver cells. They tell you something is wrong, but not what is happening to one of the liver's most important products: bile acids. These cholesterol-derived molecules do the heavy lifting of fat digestion, cholesterol elimination, and keeping the intestinal lining healthy. When bile acid levels shift, or when the balance between different types changes, it can signal problems that routine liver tests miss entirely.
This panel measures both the total amount of bile acids circulating in your blood and the individual types that make up that total. That distinction matters because the ratio between primary bile acids (made by your liver) and secondary bile acids (made by your gut bacteria) tells a different story than the total alone. A high total with normal ratios points to a bile flow problem. A normal total with shifted ratios may point to a gut bacterial imbalance or a problem with the recycling loop between your liver and intestine.
Your liver converts cholesterol into two primary bile acids: cholic acid (CA) and chenodeoxycholic acid (CDCA). These get shipped to the gallbladder, released into the small intestine after meals, and then mostly reabsorbed and returned to the liver. This recycling loop, called the enterohepatic circulation, recycles bile acids 6 to 8 times per day. When the liver, gallbladder, intestine, or gut bacteria disrupt any step in this loop, bile acid levels and ratios change in predictable ways.
Once primary bile acids reach the colon, resident bacteria convert them into secondary bile acids. Cholic acid becomes deoxycholic acid (DCA). Chenodeoxycholic acid becomes lithocholic acid, which is mostly excreted. The ratio of primary to secondary bile acids in your blood therefore reflects two things at once: how well your liver is producing and clearing bile acids, and how actively your gut bacteria are transforming them.
Total bile acids rise when the liver cannot clear them efficiently. Studies have consistently shown that serum bile acid levels are elevated in most patients with cirrhosis (severe liver scarring) and that the degree of elevation tracks with disease severity. Total bile acids above 10 micromoles per liter, the typical upper limit for fasting samples, suggest impaired liver uptake or secretion, bile duct obstruction, or portal hypertension (high pressure in the blood vessels around the liver that causes blood to bypass the liver and carry uncleared bile acids into general circulation).
Bile acids can detect liver problems earlier than standard liver enzymes in some settings. A study of patients with early-stage cirrhosis found that fasting serum bile acids were elevated in a substantial proportion of patients whose standard liver tests (ALT, AST, bilirubin) were still within normal range. This makes the panel particularly valuable when you want to catch liver stress before conventional markers move.
The individual bile acid breakdown is where this panel adds value over a total bile acid test alone. In cholestatic liver disease (conditions where bile flow is physically blocked or chemically impaired), the primary bile acids, cholic acid and chenodeoxycholic acid, rise disproportionately. The ratio of primary to secondary bile acids shifts heavily toward primary, because less bile is reaching the colon where bacteria would convert it.
In contrast, when bile flow is intact but gut bacteria are overgrown or imbalanced, you may see a relative increase in deoxycholic acid. Elevated DCA has been associated with increased colon cell growth in human studies, and population studies have linked chronically high fecal and serum DCA levels with increased colorectal cancer risk.
The power of fractionation is pattern recognition. Four common patterns cover most clinical scenarios.
| Pattern | Total Bile Acids | Cholic Acid | CDCA | Deoxycholic Acid | Likely Meaning |
|---|---|---|---|---|---|
| Cholestasis (blocked or slowed bile flow) | High | High | High | Low or normal | Bile flow is blocked or impaired; primary acids accumulate because they cannot reach the gut for bacterial conversion. |
| Liver cell damage | High | Moderately high | Disproportionately high | Variable | Liver cell injury impairs clearance; chenodeoxycholic acid (CDCA) often rises more than cholic acid (CA) in early liver disease. |
| Bacterial imbalance or overgrowth in the gut | Normal or mildly high | Low or normal | Low or normal | Elevated relative to primary acids | Gut bacteria are overconverting primary acids to secondary acids, shifting the balance. |
| Normal liver and gut function | Normal | Normal | Normal | Normal | Bile acid processing and recycling are working normally. |
In cholestasis, cholic acid typically rises more than chenodeoxycholic acid, because cholic acid is the main product of the liver's primary bile acid production route. If CDCA rises disproportionately instead, it may point toward liver cell injury rather than a bile duct obstruction. These distinctions can guide which imaging or follow-up testing makes the most sense.
Bile acid levels swing after eating. A meal triggers gallbladder contraction, flooding the intestine with bile acids and temporarily raising blood levels two- to tenfold. A fasting blood draw (at least 8 hours without food) is needed for accurate interpretation. Medications also shift results: ursodeoxycholic acid (a bile acid medication used for gallstones and certain liver conditions) directly alters the bile acid profile, bile acid sequestrants lower total levels, and antibiotics can suppress the gut bacteria that produce deoxycholic acid.
One of the most well-validated clinical uses of total bile acids is screening for intrahepatic cholestasis of pregnancy (ICP), a condition where bile flow slows inside the liver during late pregnancy, causing intense itching and increasing the risk of stillbirth. Guidelines from the Royal College of Obstetricians and Gynaecologists and the Society for Maternal-Fetal Medicine recommend serum bile acids as the primary diagnostic test for ICP. Total bile acids above 10 micromoles per liter in a symptomatic pregnant person support the diagnosis.
A meta-analysis combining data from over 5,500 women with ICP across multiple studies found that the risk of stillbirth increased significantly when total bile acid levels exceeded 100 micromoles per liter, with a stillbirth rate of 3.44% in that group compared to 0.13% in the general obstetric population. Below that threshold, stillbirth risk was not significantly elevated, though other pregnancy complications such as preterm birth were more common at lower levels. Fractionation in pregnancy can help confirm the pattern, as ICP characteristically shows elevated cholic acid with a high CA-to-CDCA ratio.
Total + Fractionated Bile Acids is best interpreted alongside these tests.